The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Evolution and future perspectives for cardiovascular interventions in China

EuroIntervention 2012;8:773-778. DOI: 10.4244/EIJV8I7A119

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
Evolution of percutaneous coronary intervention (PCI)

The first percutaneous transluminal coronary angioplasty (PTCA) performed in September 1985 in Xi’an launched a new era for coronary intervention in China.1 Although adoption of interventional cardiology was very slow during the first 10 years with only 11,735 cases being performed in 110 hospitals by 20002, many novel techniques were gradually introduced into China. Rescue PTCA after failure of thrombolysis was introduced in 1989 and direct PTCA to treat acute myocardial infarction or complicating cardiogenic shock in 19903. A few centres also performed coronary excimer laser angioplasty, directional coronary atherectomy and rotational atherectomy. Coronary stenting was introduced in 19924, and ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Europe, China and the world: the EAPCI international membership